Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia

NCT06562738 is registered in ClinicalTrials.gov with The Third People's Hospital of Chengdu as lead sponsor.

NCT NCT06562738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06562738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia
Lead sponsor
The Third People's Hospital of Chengdu
Phase
Phase 4
Overall status
Recruiting
Start date
June 1, 2024
Completion date
March 31, 2025
Enrollment
55 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thrombocytopenia